Skip to content

New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression

New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02693808
Enrollment
29
Registered
2016-02-29
Start date
2015-11-30
Completion date
2018-05-31
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid-Associated Ophthalmopathy

Keywords

Temporal hollowing, Lateral orbital wall decompression, Thyroid eye disease

Brief summary

The purpose of this study is to determine whether injection of autologous fat or hyaluronic-acid injections in temporal region are effective in the treatment of temporal hollowing after lateral wall decompression in patients with thyroid eye disease.

Detailed description

Grave's disease is one of the most common autoimmune diseases. Thyroid eye disease is affecting nearly 50% of patients with Grave's disease. Surgical treatment may address several of the manifestations, including the increased volume of the orbital contents. Decompression of the orbit can be achieved by removing the lateral orbital walls; lateral wall decompression. In a retrospective study at the Department of Ophthalmology, Haukeland University Hospital, about half of the patients had a disfiguring hollowing in the temporal region after lateral wall decompression. The patient reported outcome of the procedure is clearly an indication for further esthetic treatment. However, until now the treatment option for these patients have been limited, or simply neglected. The investigators have contacted over 40 patients with this complication that want treatment. In this project the investigators will treat bilateral hollowing with injection of autologous fat in one temporal region and hyaluronic-acid injections on the opposite side. Participants with unilateral hollowing will be randomized to one of the treatment options. Outcomes will be evaluated by clinical examination, photographs and ultrasound volume measurement at 6, 12, 18 and 24 months postoperatively. The participants will be retreated at these follow up intervals if necessary. The project will be an interventional, prospective follow-up study and is approved by the regional ethics committee. The study will be the first of its kind to date as the investigators will be able to prospectively evaluate the effect of autologous fat injections to hyaluronic-acid injections in the same patient for the same condition.

Interventions

PROCEDUREAutologous fat injection

Injection in one side with autologous fat and the other side with hyaluronic acid.

Injection in one side with autologous fat and the other side with hyaluronic acid.

Sponsors

Haukeland University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Disfiguring temporal hollowing after lateral wall decompression. * The participant want treatment for temporal hollowing Exclusion Critera: * The participant dont want treatment for temporal hollowing

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with satisfactory objective cosmetic and functional outcome2 yearsEvaluation of photographs (1 to 3/Normalized to disfiguring)

Secondary

MeasureTime frameDescription
Volume of injected substance measured by ultrasonography2 yearsml
Number and type of complications2 yearsHematoma, infection, embolization.
Number of reinjections2 yearsNumber.
Number of patients with satisfactory subjective cosmetic and functional2 yearsPatient reported perception of outcome (1 to 3/Normalized to disfiguring)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026